Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 3Prostatic Neoplasms 2Prostatic Intraepithelial Neoplasia 2Precancerous Conditions 1Osteoporosis 1Neoplasms, Hormone-Dependent 1Neoplasms 1Fractures, Bone 1Desmoid Tumors 1Carcinoma, Lobular 1Carcinoma, Ductal, Breast 1Bone Diseases, Metabolic 1

Interventions

Zoledronic Acid 4Denosumab 4Aromatase Inhibitors 2radium Ra 223 dichloride 1Vitamin D 1Toremifene 1Tobacco Products 1Letrozole 1Hormone Replacement Therapy 1Heart Disease Risk Factors 1Exercise 1Ethanol 1Cholecalciferol 1Cari-D-Tect 1Aspirin 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Fractures, Bone × Toremifene × Clear all
NCT00129142 2013-11-15

Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy

GTx

Phase 3 Completed
1,200 enrolled
Genitourinary

Bone Diseases, Metabolic, Osteoporosis, Prostatic Neoplasms, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡